(Q42737854)

6 November 2017

Prediction of veno-occlusive disease using biomarkers of endothelial injury (English)

1 reference

6 November 2017

0 references

0 references

12

1 reference

6 November 2017

13

Paul G Richardson

1 reference

6 November 2017

14

Joseph H Antin

1 reference

6 November 2017

8

Edwin Alyea

1 reference

6 November 2017

11

Robert Soiffer

1 reference

6 November 2017

2

Haesook T Kim

1 reference

6 November 2017

10

Philippe Armand

1 reference

6 November 2017

1

Corey Cutler

1 reference

6 November 2017

9

John Koreth

1 reference

6 November 2017

6

Julie Aldridge

1 reference

6 November 2017

Shaké Ayanian

3

1 reference

6 November 2017

Gary Bradwin

series ordinal

4

1 reference

6 November 2017

Carolyn Revta

series ordinal

5

1 reference

6 November 2017

Vincent Ho

series ordinal

7

1 reference

6 November 2017

23 February 2010

1 reference

Biology of Blood and Marrow Transplantation

6 November 2017

1 reference

6 November 2017

16

1 reference

6 November 2017

8

1 reference

6 November 2017

1180-1185

1 reference

Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Venoocclusive disease of the liver following bone marrow transplantation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

von Willebrand factor as a marker of endothelial cell activation following BMT.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Sirolimus accelerates senescence of endothelial progenitor cells through telomerase inactivation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2897917

Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers

16 August 2018

1 reference

12 December 2020

Endothelium and bone marrow transplantation

1 reference

12 December 2020

Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation

1 reference

12 December 2020

Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation

1 reference

12 December 2020

Plasma levels of D-dimer and circulating endothelial adhesion molecules in veno-occlusive disease of the liver following allogeneic bone marrow transplantation

1 reference

12 December 2020

Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study

1 reference

12 December 2020

Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation

1 reference

12 December 2020

Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF)

1 reference

12 December 2020

10.1016/J.BBMT.2010.02.016

Identifiers

DOI

1 reference

6 November 2017

1 reference

6 November 2017

PubMed publication ID

20184961

1 reference